Pharma Lobby Announces New Website To Connect Patients With Manufacturer-Direct Purchase Programs

The Pharmaceutical Research and Manufacturers of America (PhRMA), a lobbying organization, announced a new website on Monday that will connect patients with manufacturer-direct purchase programs.

The website, AmericasMedicine.com, is scheduled to launch in January 2026, PhRMA announced. It will allow manufacturers to list a range of medicines and connect patients directly to available options prescribed by their doctor, it added.  

Pharmacy benefit managers (PBMs) and middlemen receive massive rebates on medicines while charging patients the full price, the organization noted. Direct purchase programs thus enable patients and employers to purchase medicines at a lower cost.

The group represents several biopharmaceutical research companies, including Amgen (AMGN), Bristol Myers Squibb (BMY), and Merck (MRK). However, pharmaceutical manufacturers will make their own decisions to offer direct purchase programs, and if they want to participate in the new website, the group said.

The announcement from the group coincides with the deadline set by President Trump for 17 pharmaceutical companies, including Amgen, Boehringer Ingelheim, Bristol Myers Squibb, EMD Serono, Roche unit Genentech, Gilead, GSK, Johnson & Johnson, Novartis, Novo Nordisk, Regeneron, and Sanofi, to reduce drug prices in the U.S. to the levels paid by other wealthy countries.

The group stated on Monday that it will continue to work with the Trump administration and Congress to address the real reasons U.S. medicine prices are higher.

“To reduce price differentials with other wealthy countries, policymakers should require PBMs to share savings with patients, fix the 340B hospital markup program and force foreign governments to pay their fair share,” the lobby group said. It also noted that its member companies are making significant investments in U.S.-based manufacturing and infrastructure. 

Read also: Datavault AI Stock Jumps 13% After Announcing Partnership With IBM

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Share

·

Add us on